<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://gosset.ai/news/2026-11-19/fda-approves-venglustat-94048d31</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T23:00:00Z</news:publication_date><news:title>FDA Approves Venglustat</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-19/toludesvenlafaxine-wins-anxiety-approval-c9b8626d</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T23:00:00Z</news:publication_date><news:title>Toludesvenlafaxine Wins Anxiety Approval</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-19/solepinib-wins-dual-china-approval-e08aada2</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T23:00:00Z</news:publication_date><news:title>Solepinib Wins Dual China Approval</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-19/xanamem-misses-primary-endpoint-54e36dab</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T23:00:00Z</news:publication_date><news:title>Xanamem Misses Primary Endpoint</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-19/regeneron-announces-ash-data-e8eaa96d</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-19T23:00:00Z</news:publication_date><news:title>Regeneron Announces ASH Data</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-18/fda-approves-infilbray-fb51e46e</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:00:00Z</news:publication_date><news:title>FDA Approves Infilbray</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-18/gevalka-wins-eu-approval-4b1e5817</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:00:00Z</news:publication_date><news:title>Gevalka Wins EU Approval</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-18/merck-ends-nemtabrutinib-development-794d199f</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:00:00Z</news:publication_date><news:title>Merck Ends Nemtabrutinib Development</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-18/dayvigo-korea-launch-planned-a3ed46d1</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:00:00Z</news:publication_date><news:title>Dayvigo Korea Launch Planned</news:title></news:news></url>
  <url><loc>https://gosset.ai/news/2026-11-18/fda-clears-masimo-smartsedline-884198e2</loc><news:news><news:publication><news:name>Gosset News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-18T23:00:00Z</news:publication_date><news:title>FDA Clears Masimo smartSedLine</news:title></news:news></url>
</urlset>
